SUMMARY -A 70-year-old patient was admitted to the Department of Oral Medicine for multiple oral ulcerations on the left buccal mucosa, around 0.5 cm in diameter, as well as on the gingiva. Otherwise, the patient suff ered from chronic lymphocytic leukemia, hypogammaglobulinemia, chronic renal insuffi ciency, with complete afunction of the right kidney, asthma, hypertension, gastritis and prostate hyperplasia. Diff erential diagnosis of oral ulcerations included drug induced oral ulcerations, paraneoplastic pemphigus, viral ulcerations (cytomegalovirus, herpes simplex viruses), fungal ulcerations (candidiasis, aspergillosis, histoplasmosis, cryptococcosis) and bacterial ulcerations, as well as neutropenic ulcers. One of the possible explanations was that the lesions were due to the use of drugs, the more so as oral lesions evolved when the doses of allopurinol and chlorambucil were increased, and subsided when the doses of both drugs were decreased. However, we could not establish for sure whether the lesions were due to allopurinol or chlorambucil. According to literature data, allopurinol is one of the most frequent drugs known to induce skin adverse reactions, therefore we assumed that it was the culprit drug. Unfortunately, several weeks later the patient died from sepsis, pneumonia with respiratory insuffi ciency and multiorgan failure.
Introduction
Sometimes it is very diffi cult to fi nd out what is the exact cause of oral ulcers, especially in patients that are immunosuppressed and take many drugs. Oral ulcers can be induced by the following causes: 1) traumatic; 2) microbial (viral, bacterial and fungal); 3) autoimmune mediated such as recurrent aphthous ulcers; 4) related to systemic diseases such as gastrointestinal (gluten enteropathy and Crohn's disease) and hematopoietic ones such as iron defi ciency and neutropenia; 5) vesiculobullous diseases such as pemphigus, pemphigoid; 6) malignant oral diseases such as oral squamous cell carcinoma, diff use large B cell lymphoma and metastases; 7) self-infl icted lesions in psychiatric patients such as bulimia; 8) adverse drug reactions; and 9) neutropenic ulcerations 1 . Oral ulcers are well known side eff ects of drug therapy; however, their exact etiopathogenesis is poorly understood. It is important to defi ne when the ulcerations began, or if they worsened de novo upon increased drug dosage 2 , as in our case. It is well known that nonsteroidal anti-infl ammatory drugs (NSAIDs) and beta blockers (labetalol, captopril, nicorandil) may lead to the development of oral ulceration. Nicorandil induced oral ulcerations are probably caused by its metabolites. It is known that there are large individual variations in the activity of enzyme nicotinamide N-methyltranferase that catalyzes methyl conjugation of nicotinamide, an intermediate formed by denitration of nicorandil. NSAIDs may cause mucosal ulceration due to local vasoconstriction. Mouth ulcers can occur as side eff ects of immunosuppressive therapy which may lead to activation of herpes virus or other viruses such as cytomegalovirus (CMV). Phenylbutazone can cause agranulocytosis which may manifest with oral ulcerations. Th e only proper diagnosis of the drug-induced oral ulceration is re-challenge, which is unethical unless the drug is unreplaceable. Re-challenge poses the risk of anaphylactic reaction 3 . Oral adverse reactions to drugs depend on the dose and type of medication, as well as on individual diff erences related to the patient. Oral adverse reactions to drugs may be rapid but can also develop a few years after the drug has been initiated. In most drug-induced oral reactions, improvement of clinical symptoms occurs after dose reduction or upon discontinuation of the off ending drug 4, 5 . Hernandez et al. 6 have described a case of a patient in whom resolution of oral ulceration occurred after decreasing the dosage of tacrolimus. It seems that this phenomenon may be related to the drug half-life. Of course, severe reactions require rapid withdrawal of the off ending drug.
So far, some drugs have been implicated in the etiology of oral ulcers such as sodium lauryl sulfate, sertraline hydrochloride, NSAIDs, ferrous sulfate, lamotrigine, tacrolimus, mycophenolate mofetil, sirolimus, nicorandil, captopril, labetalol, calcium channel blockers, foscarnet, alendronate, protease inhibitors, interferon and 2'3'-dideoxycytidine, aspirin, pancreatic supplements, metamizole, tiotropium bromide and sulfonamides 7 .
Case Report
A 70-year-old male patient was referred to our Department. Clinically, the lesions appeared as three oral ulcerations on his left buccal mucosa approximately 0.5 cm in diameter and the same type of lesions could be seen on the upper and lower gingiva ( Figs. 1 and 2) . Th e whole oral mucosa was thinned and pale.
Detailed medical history revealed that he suff ered from chronic lymphocytic leukemia, hypogammaglobulinemia, chronic renal insuffi ciency, with complete afunction of the right kidney, asthma, degenerative laryngopathy, hypertension, gastritis and prostate hyperplasia.
Upon admission to our Department, he was taking methylprednisolone (Medrol), aciclovir (Herplex), pantoprazole (Controloc), allopurinol (Alopurinol), lercanidipine (Lercanil), losartan (Losartic), ciclesonide (Alvesco), albuterol sulfate (Ventolin), loratadine (Rinolan), tamsulosine (Omnic), diazepam (Normabel), budesonidum (Tafen) and montelukast (Melarth).
Complete blood count revealed the following fi ndings: L 4.0 (x10 9 ) (normal range 3.4-9.7); erythrocytes 3.71 (x10 Histopathologic fi nding showed granulation tissue with rare to medium abundant mononuclear infl ammatory infi ltration; however, no macrophages with inclusions were seen. Direct and indirect immunofl uorescence (DIF and IIF) fi nding showed no immunoglobulin and complement deposits.
At presentation, we thought the patient had CMV induced oral lesions and he was referred for viral blood tests (real time PCR, Qiagen CMV LC PCR Kit), which revealed CMV viremia. He was immediately administered valaganciclovir therapy together with acyclovir, fl uconazole and azithromycin, with local improvement. Our working diagnosis was drug (allopurinol or chlorambucil) induced oral ulceration, as the lesions started when allopurinol dose was increased from 100 mg to 300 mg and subsided when allopurinol dose was 200 mg. At the same time, chlorambucil was reduced from the dose of 16 mg to 2 mg because leukocyte number was normalized. Th e lesions began to heal (Fig. 3) . Unfortunately, several weeks later, the patient died from sepsis, pneumonia with respiratory insuffi ciency and multiorgan failure.
Discussion
Notwithstanding the clinical importance of treatment-related toxicities, dermatologic and mucosal disturbances may also precede, coincide or follow the diagnosis of cancer. Th is case was quite peculiar due to the simultaneous occurrence of oral ulceration and certain systemic conditions which may have led to the development of oral ulceration in this patient. Th e histopathologic fi nding was not suggestive of viral infection (neither herpes nor CMV) or fungal infection. Moreover, immunohistochemistry of oral lesions did not reveal the presence of either CMV or herpes simplex virus (HSV). DIF and IIF were also negative, therefore the diagnosis of pemphigus, paraneoplastic pemphigus and pemphigoid was discarded. We thought that maybe this was fungal infection (candidal or cryptococcal), as the lesions cleared when fl uconazole was introduced, however, no fungi were found in the histopathology specimen.
At the end, our working diagnosis was drug (allopurinol or chlorambucil) induced oral ulceration, as the lesions started when allopurinol dose was increased from 100 mg to 300 mg and the lesions subsided when allopurinol dose was reduced to 200 mg as kidney function improved. At the same time, chlorambucil was reduced from the dose of 16 mg to 2 mg because leukocyte count was normalized. It is well known that allopurinol dose increase leads to the more frequent occurrence of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). Furthermore, the use of 200 mg or more of allopurinol daily was associated with a higher risk of SJS or TEN compared with lower daily doses, as reported by Halevy et al. 8 . Th ere have been few case reports on skin granuloma annulare in patients as a side eff ect of allopurinol; however, to our knowledge, there are not many case reports on Pubmed on oral manifestations of allopurinol therapy. Abdollahi and Radfar 9 have reported that allopurinol might induce erythema multiforme, oral ulceration and oral lichenoid changes. Marra and Wunderle 10 report the fi rst case of toxic epidermal necrolysis associated with allopurinol therapy, which initially presented with oral ulceration. Chau et al. 11 describe oral lichenoid reactions due to allopurinol therapy in four patients.
We cannot describe the underlying mechanism by which allopurinol might lead to development of oral ulcers. It is possible that the mechanisms include immune complex deposition, an immune response directed against the metabolites of allopurinol or allopurinol hypersensitivity exclusively localized to oral mucosa, as it has been described for allopurinol induced skin lesions such as granulomatous dermatitis 12, 13 .
Fig. 3. Healed lesions on buccal mucosa.
Regarding chlorambucil, there have also been few case reports on oral and skin induced lesions. Pietrantonio et al. 14 have reported a case of a patient who developed confl uent maculopapular erythema and large fl accid bullae on the trunk, legs and mucous membranes, with fever up to 38 °C. TEN was confi rmed by skin patch test followed by skin biopsy.
Levin and Libster have reported two cases of high fever and progressive lymphadenopathy in patients treated with chlorambucil. Th e authors conclude that allergic reactions to chlorambucil are rare, however, previously urticaria, angioedema, rashes, TEN, drug fever and one case of immune hemolytic anemia have been described 15 . Th e case presented shows that oral fi nding looking like a CMV infection probably was a drug-induced oral lesion (due to either allopurinol or chlorambucil).
